8 Medications and Supplements to Avoid with IBD

Managing inflammatory bowel disease requires careful attention to daily triggers, but everyday medications—including common over-the-counter drugs—can also provoke gastrointestinal distress and increase the likelihood of a flare, according to gastroenterologists. Certain pharmaceuticals aggravate gastrointestinal side effects already common in Crohn’s disease and ulcerative colitis, while others alter the delicate gut microbiome. Understanding these specific medication risks allows patients to collaborate more effectively with their healthcare providers to avoid unexpected complications.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Popular pain relievers such as ibuprofen and naproxen are generally discouraged for people managing Crohn’s disease or ulcerative colitis because they can heighten flare risks. According to Dr. Kelsey Able, a gastroenterologist at Consultants in Gastroenterology and a supervising clinical practitioner at Kansas City University College of Osteopathic Medicine, the frequency of use directly dictates the level of danger.

The higher the frequency, the greater the risk.

Dr. Kelsey Able, Consultants in Gastroenterology

For everyday pain management, non-NSAID options like acetaminophen typically present a safer alternative for IBD patients. Doctors may also consider COX-2 inhibitor NSAIDs such as celecoxib because they carry a lower potential flare risk than traditional NSAIDs. However, specific medical scenarios warrant cautious use under physician supervision. Low-dose aspirin remains acceptable for cardiovascular protection, and Dr. Iana Stonier, codirector of the inflammatory bowel disease center at Henry Ford Health in Detroit, notes that pregnant patients with IBD often receive two low-dose aspirin in collaboration with obstetrics and gynecology departments after the twelfth week of pregnancy to prevent preeclampsia.

Broad-Spectrum Antibiotics and Gut Bacteria

Antibiotics frequently disrupt the bacterial balance inside the gastrointestinal tract, which can trigger an IBD flare. Research indicates that the highest risk occurs within two weeks of taking broad-spectrum oral antibiotics—such as quinolones, penicillins, nitroimidazoles, and macrolides—that target a wide range of bacteria. Conversely, intravenous antibiotics do not appear to carry the same elevated flare risk. When infections require antimicrobial treatment, physicians emphasize strict stewardship.

Broad-spectrum antibiotics require judicious use. While clinical indications vary, therapy should always align with established guidelines and evidence-based antibiotic stewardship.

Dr. Iana Stonier, Henry Ford Health

Proton Pump Inhibitors (PPIs)

Medications like omeprazole, lansoprazole, and esomeprazole effectively treat acid reflux, but studies link long-term proton pump inhibitor use to greater IBD severity and reduced remission rates. Gastroenterologists typically advise Crohn’s and ulcerative colitis patients to avoid extended PPI regimens. When acid reflux causes persistent discomfort, specialists may suggest lifestyle modifications or histamine-2 blockers such as famotidine before turning to acid-suppressing drugs. For patients requiring a PPI, short-term prescriptions utilizing the lowest effective dose help mitigate potential risks, according to Dr. Stonier.

Antidiarrheal and Laxative Precautions

Antidiarrheal drugs like loperamide slow bowel motility and firm up stool, but they can prove dangerous for individuals with bowel strictures or active inflammation. Dr. Able advises patients to consult their gastroenterologist before using these agents, as improper use can provoke toxic megacolon, a severe complication where the colon fills with gas and ruptures, allowing bacteria to enter the bloodstream. Similarly, patients experiencing constipation must evaluate laxative options carefully with a physician. Laxatives are unsafe for individuals with strictures, and doctors typically start with increased water intake, dietary fiber, or bulk-forming supplements like psyllium before considering osmotic laxatives such as polyethylene glycol, keeping in mind that these treatments can sometimes induce cramping or gas.

GLP-1 Receptor Agonists and Opioid Pain Relievers

Glucagon-like peptide-1 receptor agonists like semaglutide and tirzepatide are generally safe for individuals with IBD, but their common side effects—including nausea, vomiting, and diarrhea—can compound existing symptoms. Furthermore, appetite suppression from these weight-loss and diabetes medications can accelerate nutritional deficiencies in patients already vulnerable to malnourishment.

With any patient on these meds, careful nutritional goals and practices should be followed to avoid malnourishment due to rapid weight loss.

Dr. Kelsey Able

Opioid pain relievers present even greater hazards and are reserved for severe pain unresponsive to other treatments. Gastroenterology guidelines strongly discourage opioid use in IBD populations because these drugs can accelerate inflammation, cause bowel obstructions, and heighten infection and mortality risks. Uncontrolled pain often signals underlying, unmanaged IBD activity, prompting doctors to adjust primary disease therapies rather than adding narcotics.

Magnesium Supplements

While magnesium supplements are widely used to improve sleep quality, ease muscle cramps, and combat fatigue, they can irritate the digestive tract and intensify diarrhea or loose stools. Selecting the correct chemical formulation helps minimize adverse reactions. Dr. Able notes that magnesium glycinate is typically gentler on the digestive system than magnesium oxide or magnesium citrate, which tend to worsen loose stools in IBD patients. Medical professionals recommend consulting a physician before integrating any new dietary supplement into a daily regimen.